Table 5.
Relationship between the therapeutic group and the perceived burden, measured by the LMQ-3 score.
Therapeutic Group | Results of Linear Regression Analysis | Mean LMQ-3 Score | ||||
---|---|---|---|---|---|---|
B | 95% CI | p Value | Present (n) | Not Present (n) | p Value * | |
Cardiovascular | −3.28 | −9.66; 3.09 | 0.311 | 93.7 (103) | 95.6 (64) | 0.521 |
Respiratory | −0.02 | −7.34; 7.30 | 0.996 | 97.4 (31) | 93.7 (135) | 0.319 |
Gastro-intestinal | 5.19 | −1.89; 12.27 | 0.150 | 100.2 (50) | 91.8 (116) | 0.007 |
Psychiatric | 2.83 | −3.60; 9.27 | 0.386 | 98.0 (59) | 92.2 (126) | 0.043 |
Neurological | 7.05 | 0.07; 14.03 | 0.048 | 100.7 (55) | 91.3 (130) | 0.001 |
Endocrine | −3.37 | −10.43; 3.68 | 0.346 | 94.0 (97) | 94.5 (129) | 0.618 |
Skin | −4.59 | −13.31; 4.13 | 0.300 | 94.3 (21) | 94.4 (145) | 0.985 |
Musculo-skeletal | 3.33 | −4.79; 11.45 | 0.419 | 101.4 (28) | 92.9 (138) | 0.491 |
Note: * T-test.